Neuropeptide synthesis was determined for individual identified ventral-cluster neurons in the buccal ganglia of Aply sia. Each of these cells was shown to be a motor neuron that innervates buccal muscles that generate biting and swallowing movements during feeding. Individual neurons were identified by a battery of physiological criteria and stained with intracellular injection of a vital dye, and the ganglia were incubated in %-methionine. Peptide synthesis was determined by measuring labeled peptides in extracts from individually dissected neuronal cell bodies analyzed by HPLC. Previously characterized peptides found to be synthesized included buccalin, FMRFamide, myomodulin, and the 2 small cardioactive peptides (SCPs). Each of these neuropeptides has been shown to modulate buccal muscle responses to motor neuron stimulation.
Two other peptides were found to be synthesized in individual motor neurons. One peptide, which was consistently observed in neurons that also synthesized myomodulin, is likely to be the recently sequenced myomodulin B. The other peptide was observed in a subset of the neurons that synthesize FMRFamide. While identified motor neurons consistently synthesized the same peptide( neurons that innervate the same muscle often express different peptides.
Neurons that synthesized the SCPs also contained SCP-like activity, as determined by snail heart bioassay.
Our results indicate that every identified motor neuron synthesizes a subset of these methioninecontaining peptides, and that several neurons consistently synthesize peptides that are likely to be processed from multiple precursors.
Many neurons contain multiple transmitters. Often, 1 or more peptide cotransmitters are localized with a single conventional transmitter. We have chosen to study the role of peptide cotransmitters in a model system consisting of identified motor neurons in the buccal ganglia of Aplysia. These motor neurons generate the cyclic feeding motor output that drives biting and swallowing movements of muscles of the buccal mass (Gardner, 197 1; Kupfermann, 1974) . Previous results indicate that at least 5 methionine-containing peptides are synthesized in buccal ganglia and transported to buccal muscle (Lloyd, 1988) . These pep-tides were identified as myomodulin (Cropper et al., 1987b) , the 2 small cardioactive peptides (SCP,, Lloyd et al., 1987a; SCP,, Morris et al., 1982) FMRFamide (Price and Greenberg, 1977) , and buccalin . Peptides synthesized in buccal ganglia are not transported uniformly to individual buccal muscles. Different muscle groups received different complements of peptides, and the peptides are transported in different amounts in particular nerves (Lloyd, 1988) . Each of the 5 peptides has been shown to modulate the efficacy of motor neurons in producing buccal muscle contractions. However, both the nature and the underlying mechanism of the modulation vary for different buccal muscles. For example, in intrinsic muscle 5 (IS; also termed the accessory radula closer muscle), the SCPs enhance, while FMRFamide decreases, the amplitude of contractions produced by stimulation of motor neurons (Lloyd et al., 1984; Weiss et al., 1986) . However, the SCPs and FMRFamide both enhance contractions of an extrinsic buccal muscle (Richmond et al., 1986) , and the SCPs have been shown to enhance contractions of another intrinsic muscle, but by a different mechanism than in 15 (Lotshaw and Lloyd, 1990) .
The observation that the peptides mentioned above are selectively synthesized in individual neurons, are selectively transported to individual buccal muscles, and are each capable of modulating motor-neuron-evoked contractions strongly suggests that they function as modulatory transmitters in buccal muscle. The evidence that the SCPs serve such a role is particularly strong. The SCPs are located in dense-core vesicles in varicosities in the CNS and buccal muscle and are released from identified neurons in culture in a stimulation-and calcium-dependent manner (Kreiner et al., 1986; Lloyd et al., 1986; Cropper et al., 1988; Reed et al., 1988) . Cholinergic motor neuron BlS synthesizes the SCPs and innervates the 15 muscle (Cohen et al., 1978; Cropper et al., 1987a) . Two independent procedures have been used to demonstrate release of the SCPs from B 15 terminals in I5 muscle (Whim and Lloyd, 1989) . Release of SCPs occurs only when B 15 is stimulated at a relatively high frequency with a long burst duration. Because B 15 can produce cholinergically mediated contractions with stimulation parameters that would not cause measurable release of the SCPs, it appears that B 15 can function in 2 states: as a predominantly cholinergic neuron or as a combined cholinergic/peptidergic neuron. Similar results describing the release of the SCPs from B 15 terminals in I5 muscle during stimulation of B 15 in a pattern similar to that observed during feeding have recently been reported by Cropper et al. (1990) . Finally, SCPs released from B 15 terminals have been shown to modulate contractions evoked by stimulation of a second cholinergic motor neuron that innervates the 15 muscle (B16; Whim and Lloyd, 1990 with an injection of isotonic M&I,. The dissection was carried out in a high-Mg2+ (110 mM), low-Caz+ (2 mM) ASW and was similar to that previously described (Whim and Lloyd, 1989) . In brief, the buccal mass/ buccal ganglia complex was removed from animals, and all nerves were severed except buccal nerves 2 and 3 or, in some preparations, the radula nerve (nerve designations from Gardner, 1971) . None of the neurons identified in this study had major axons projecting out buccal nerve 1. The ganglia were pinned to a small Sylgard platform and desheathed, and the preparation was superfused with normal ASW for l-2 hr. Motor neurons were identified by their position, size, nature of synaptic input from neurons B4 or B5 (Gardner, 197 l) , and ability to produce contractions in particular muscles when stimulated with intracellular current injections (Table 1) . In some experiments, compound excitatory junction potentials (EJPs) were recorded from muscles using a suction electrode and a Grass P15D AC amplifier. Similar procedures were used to record action potentials in nerves following intracellularly driven action potentials in identified neuronal somata. This permits the identification of the primary axonal projections of the neuron. Buccal muscle nomenclature was taken from Howells (1942) . In addition, we include a newly described pair of muscles (17s) which are medial to the I5 muscles and project from the base of I6 to the connective tissue covering the radular sac. In all neuromuscular experiments, the ganglia were selectively superfused with high-Mg2+, low-Cal+ solution by means of a small tube placed immediately adjacent to the ganglia, while the remainder of the bath containing the buccal muscles was superfused with normal ASW.
Peptide synthesis in identified neurons. Characterized neurons were electrophoretically injected with a vital stain (1% fast green) via an intracellular electrode for later identification. Control experiments comparing stained and unstained neurons indicated that fast green had no effect on peptide synthesis. Isolated desheathed ganglia were repinned in a small dish, and newly synthesized peptides were labeled with 15S-methionine by incubation in a 0.5-ml solution of 50% Aplysia hemolymph, 50% ASW containing 1 mM colchicine, 25 U/ml penicillin, 25 &ml streptomycin, 0.1% 2-mercaptoethanol, and 1 mCi/ml YS-methionine (Amersham; stabilized with pyridine 3,4-dicarboxylic acid) for 20 hr at 16°C followed by a 4-hr chase in ASW containing colchicine, antibiotics, mercaptoethanol (as above), and 1 mM cold methionine. In some experiments, the colchicine that was added to inhibit axonal transport of the peptides (Lloyd, 1988) was omitted from both label and chase solutions. Results from these experiments did not differ qualitatively or quantitatively from experiments conducted in the presence of colchicine. Only results from experiments with colchicine are presented in this study. Individual neuronal cell bodies were dissected using the freeze substitution method (Ono and McCaman, 1980) , and single identified neurons were transferred to microtubes containing 50 ~1 0.02 M trifluoroacetic acid (TFA) and 1 nmol each of synthetic buccalin (American Peptide Co.), FMRFamide (Bachem), pedal peptide (Applied Biosystems), myomodulin, SCP,, and SCP, (Peninsula). Tubes were heated at 100°C for 10 min, and the samples were cooled and filtered through 0.45~pm Acre LC13 filters (Gelman). Samples were analyzed by reversephase HPLC on a Brownlee RP-300 C8 column. The initial separation used a 3-part gradient, from 25% to 29% CH,CN in 2 min, from 29% to 35% CHCN in 12 min. and from 35% to 45% CH,CN in 6 min. at a flow rate of 2 ml/min. Both aqueous and CH,CN somtions contained 0.01 M heptafluorobutyric acid (HFBA). This gradient effectively resolved each of the synthetic peptides from each other (Fig. 1 ). Fractions were collected at 0.4-min intervals, aliquoted, and liquid scintillation counted. Some fractions were also subsequently analyzed using a second a Indicates muscle regions that contracted in response to relatively low-frequency firing of each motor neuron. In addition, multiaction neurons 84 and B5 provide inhibitory or mixed excitatory/inhibitory junction potentials that did not elicit contractions in the 13 muscle (also see Nagahama and Takata, 1990) Values are mean ? SEM with each neuron taken from a minimum of 4 preparations. Threshold sensitivity was about 10 fmol/neuron extract.
gradient. Aliquots from the radioactive peaks of interest were pooled, dried, and run on a linear gradient from 5% to 54% CH,CN in 20 min at 2 ml/min. In these runs, the aqueous and CH,CN solutions contained 0.01 M TFA. Fractions of 0.4 or 0.2 min were counted. Elution profiles of the synthetic peptides were determined from absorbance at 2 15 nm. In total, 136 neurons were analyzed from 25 buccal ganglia preparations.
Measurement of SCPs in identified neurons. Characterized neurons
were stained with fast green, dissected, and extracted as described above, except the TFA solution contained 0.5 nmol [Tyr*] substance P (Bathem) and no other peptides. [Tyr*] substance P acts as an effective carrier for the SCPs (Whim and Lloyd, 1989) . Extracts were dried, and the SCP-like activity present in them was measured using the isolated snail heart bioassay. This bioassay has been described previously (Lloyd, 1978) and was used because it is sufficiently sensitive to measure SCPs from single neurons and, over a small range, the increase in amplitude of spontaneous heart beats is linearly proportional to the amount of the SCPs in the injection (Lloyd, 1986) . Hearts were calibrated before and after test samples with injections of SCPs (5, 10, and 20 fmol each of an equimolar mixture of SCP, and SCP,). Control experiments using amounts of synthetic SCPs similar to that found in cell extracts indicated that there was a -75% recovery of bioactivity down to the level of lO-20 fmol.
[Tyrs] substance P was nearly completely inactive in the assay. The ratios of the activity of either of the SCPs to the activity of other substances on the heart were as follows: buccalin, > 10"; FMRFamide, 3354 ? 1065; myomodulin, 7619 f 4622; and serotonin, 3.3 _+ 1.3 (*SD; N = 4 or 5 heart preparations). Thus, only serotonin had significant activity on the heart assay. In total, 92 neurons were analyzed from 12 buccal ganglia preparations.
Results

Identification of ventral-cluster motor neurons
Most of the larger motor neurons (260 wrn diameter) in the ventral cluster can be identified unequivocally by a combination of their size, position (Fig. 2) , and several physiological criteria. Most ventral-cluster motor neurons receive similar inhibitory synaptic input from neurons B4 and B5, which have both interneuronal and motor functions. However, input from B4/BS was useful in identifying 2 neurons. B7 receives biphasic excitatory/inhibitory synaptic input, while B38 was the only ventralcluster neuron we have studied that never received synaptic input from B4/B5 (Gardner and Kandel, 1977; Lotshaw and Lloyd, 1990) . The most useful of the physiological criteria was the location of the muscle fibers innervated by the neuron. Usually, this was determined by the location of contractions produced by intracellular stimulation of a neuron. The location of fibers innervated by each of the identified neurons was confirmed by demonstrating that extracellularly recorded EJPs followed intracellular action potentials with fixed latencies at frequencies of at least 10 spikes/set. In these experiments, the ganglia were selectively superfused with low-Ca*+ ASW to inhibit central synaptic transmission.
Neurons were numbered based loosely on the neuronal maps of Gardner (197 l) , with the addition of B38 (Lotshaw and Lloyd, 1990 ) and 5 newly identified neurons (B8b, B39, B43, B44, and B45). In 2 cases, the only criterion that could be used to differentiate between adjacent neurons was their position relative to each other within a ganglion. Because this appeared to us to be the weakest of the criteria, these identifications must be considered tentative. We indicate the inability to unequivocally identify a neuron as an individual by a letter following the neuron designation number (B8a and B8b). In addition, the previously identified B4 and B5 can only be distinguished by their relative positions and should also be included in this category (Gardner and Kandel, 1977; Rosen et al., 1982) . Table 1 summarizes the characteristics of the 17 identified ventral-cluster motor neurons that were analyzed for peptide synthesis in the present study.
Peptide synthesis in identified motor neurons
Incubating ganglia with radiolabeled amino acids followed by running extracts of the neuronal cell bodies on HPLC permits identification of multiple peptides synthesized by a neuron and indicates position and relative size of neurons in the cluster. Cnteria used to identify neurons are given in also provides quantitative measurements of the rates of this synthesis. In addition, by running several modes of HPLC, the chemical identification of a labeled peptide can be confirmed. Thus, this procedure provides major advantages over immunocytology. Neurons were identified as described above, injected witli fast green, and incubated in 35S-methionine. After incubation and chase periods, individual cell bodies were dissected from the ganglia, extracted, and run on HPLC with HFBA as a counterion. Overall, 7 patterns of synthesis of methioninecontaining peptides were observed in ventral-cluster neurons. Three of the patterns consisted of labeled peptides that may be processed from single precursors (Fig. 3) . The most common pattern, consisting of the 2 SCPs, was found in B6, B9, BlO, B38, and B43. A pattern consisting of FMRFamide (see below) was found in B3, B4, B5, and B39. A pattern consisting of myomodulin and a second, smaller peak was observed in B8a, B8b, B44, and B45. . Examples of HPLC of extracts from neurons that synthesize peptides that may be processed from single precursors. Cell extracts were run with HFBA as a counterion (see Fig. 1 ). B3 is an example of a neuron that synthesizes primarily Fh4RFamide (Fa; see Fig. 5 ). B8a is an example of a neuron that synthesizes primarily myomodulin (Mm) and a smaller peak with longer retention time that includes myomodulin b. BZO is an example of a neuron that primarily synthesizes the SCPs (4 and B). Retention times of synthetic peptides are indicated by the dashed lines. In this and the following figure, unincorporated 15S-methionine is the predominant component of the large truncated peak with brief retention time (O-3 min). The peaks of radiolabel with a retention time about 2 min shorter than buccalin (Bn) were observed in extracts from every neuron (also see Fig. 4 ). The identity of this peak has not been determined. Peptide identities were confirmed by running aliquots from these peaks on HPLC with TFA as a counterion (e.g., Fig. 5 ).
Four patterns of labeled peptides were observed in which the peptides were likely to be products of multiple precursors (Fig.  4) . One pattern, which was found in Bl 1, consisted of the synthesis of myomodulin and the SCPs. The most complex pattern was observed in B7 and consisted of the synthesis of FMRFamide, myomodulin, and the SCPs (Fig. 4) . We also confirmed that B15 synthesized the SCPs and buccalin, and that B16 synthesized myomodulin and buccalin ( Fig. 4 ; Cropper et al., 1987a Cropper et al., , 1988 Kupfermann et al., 1988) . Small peaks that coincided with myomodulin and FMRFamide were occasionally observed in B15, but these have not been further analyzed. 8 16 min Figure 4 . Examples of HPLC of extracts from neurons that synthesize peptides that are likely to be processed from multiple precursors. Cells were run with HFBA as a counterion (see Fig. 1 ). Retention times of synthetic peptides are indicated by the dashed lines. 87 synthesizes FMRFamide (Fu), myomoduhn (Mm), and the SCPs (A and B). Bll synthesizes myomodulin and the SCPs. BZ5 synthesizes buccalin (Bn) and the SCPs, while B16 synthesizes buccalin and myomodulin. Peptide identities were confirmed by running aliquots from the peaks on HPLC with TFA as a counterion (e.g., Fig. 5 ).
In the myomodulin pattern, the ratio of myomodulin to the smaller peak with a longer retention time was 5.27 + 0.98 (*SD; N = 18; range, 3.4-7.1). Neurons B8a, B8b, B 16, B44, and B45 were used to generate this ratio, while myomodulin-synthesizing neurons B7 and Bl 1 were not because the second peak was contaminated slightly by the onset of the SCP, peaks. This uniform ratio is consistent with the interpretation that the second peak is processed from the same precursor as myomodulin and is likely to include the recently sequenced myomodulin B For neurons B3 and 839, a major peak continued to coelute with synthetic FMRFamide, while a second peak eluted with a longer retention time and 2 small peaks had shorter retention times than that of synthetic FMRFamide.
because it was also found in B16, where it has been previously identified . Aliquots from the labeled peaks for each identified neuron were also run on a second mode of HPLC with TFA as a counterion to confirm peptide identifications.
The labeled SCPs, myomodulin, and buccalin peaks from the first mode of HPLC always continued to coelute precisely with the appropriate synthetic peptides in the second mode of HPLC. The peaks in neurons B3 and B39 appeared to be broader than the absorbance peak produced by synthetic FMRFamide in the first mode of HPLC, and when aliquots of these peaks from B3 and B39 were run individually in the second mode of HPLC, they each resolved into 2 major and 2 minor labeled peaks (Fig. 5) . The predominant peak had the same retention time as FMRFamide, while the second major peak had a longer retention time. These results are not likely to be due to chemical modification of FMRFamide because the synthetic peptide was treated in an identical fashion and did not produce the second peak. The ratio of the peaks in B3 and B39 varied considerably even for the same neuron from different preparations. The FMRFamide peak from other neurons (B4, BS, B7) produced a single peak with retention times identical to synthetic FMRFamide when run on the same gradient. Thus, it is possible that more than 1 precursor is being expressed in B3 and B39, though differences in precursor processing cannot be ruled out (e.g., Fisher et al., 1988) .
A composite of the overall results for peptide synthesis in identified neurons is shown in Figure 6 . The data in this figure are presented as incorporation into a peptide as a percentage of total radioactivity recovered from the HPLC run to compensate for the wide range in size of neuronal cell bodies (see Fig. 2 ). Although occasionally individual neurons or even all the ventral-cluster neurons in a particular ganglion did not show significant incorporation of labeled methionine into peptides, when
El Bn
El Fa 0 Mm n SCPS Neuron Designation Figure 6 . Peptide synthesis in identified ventral-cluster neurons. Incorporation into peptides is represented as the percentage of total radioactivity recovered from the HPLC run to compensate for the wide range of sizes of the neuronal cell bodies. In addition, the radioactivity associated with myomodulin or SCP, was divided by 2 because these peptides contain 2 methionine residues. Values are mean & SD, with each neuron analyzed from a minimum of 3 preparations. Occasionally, B15 and B39 extracts contained small peaks of radioactivity that coeluted with synthetic myomodulin. These peaks contained insufficient radioactivity to confirm peptide identity on a second HPLC gradient. Peptides: buccalin (Bn), FMRFamide (Fu), myomodulin (Mm), and SCPs.
incorporation did occur, particular identified neurons synthesized the same peptide( Of the 17 neurons studied, 8 synthesized the SCPs, 8 synthesized myomodulin, and 5 synthesized FMRFamide. In addition, 3 small, unidentified neurons in the B8 cluster also synthesized myomodulin. Only the 2 neurons (B15 and B16) that innervate the 15 muscle synthesized measurable quantities of buccalin. Finally, neurons with indistinguishable physiological properties (B4 and B5, B8a and B8b) synthesized very similar levels of the same peptides (Fig. 6) .
Measurement of the SCP content of identified motor neurons In order to estimate how the rates of synthesis compared to peptide content in the ventral-cluster neurons, we took advantage ofthe sensitive snail heart bioassay to measure the amounts of cardioactive substances in extracts from identified neurons. Buccalin, FMRFamide, and myomodulin are each at least lOOOfold less potent than the SCPs in the bioassay (see Materials and Methods). Serotonin is only about 3-fold less active, but no serotonergic neurons are located in the buccal ganglia, and the amounts of serotonin present in terminals on neuronal somata are too low to be measured in this assay (Schwartz and Shkolnik, 198 1; Ono and McCaman, 1984) . Table 1 summarizes the values obtained for the SCP content of identified ventralcluster neurons. Only those neurons that were found to synthesize the SCPs contained measureable cardioactive substances. This independently confirms the specificity of the 'S-methionine-labeling procedure. In general, identified neurons that synthesized the most labeled SCPs also contained the largest amounts of the SCPs, though this relationship was not invariant, because B38 contained less of the SCPs than would have been predicted from the labeling studies. Thus, for the SCPs, the observed rates of synthesis reflect the presence of about 50-250 fmol of SCP, and SCP, per neuronal somata.
Discussion
Every motor neuron in the ventral cluster analyzed in our study synthesized methionine-containing peptide cotransmitter(s). Where previous studies had localized peptides to identified neurons, our studies confirmed synthesis of those peptides (Cropper et al., 1987a Kupfermann et al., 1988; Church et al., 199 1) . Although there was some variability in our quantitative measurements of peptide synthesis, it appears that the particular peptides expressed in a given neuron were consistent from animal to animal.
The expression of methionine-labeled peptides may also reflect the presence of other peptides that do not contain methionine residues and are processed from the same precursor. For example, a cDNA that encodes buccalin may also encode an additional 9 related peptides, including buccalins B and C, which have recently been sequenced Miller et al., 1989) . These buccalins do not contain methionine and have been localized to motor neurons B15 and B16. The SCPs' precursor encodes single copies of SCP, and SCP, and also contains addition potential cleavage sites . The FMRFamide precursor encodes for multiple copies of FMRFamide but also contains additional regions that may be processed into peptides with no sequence similarity to FMRFamide (Taussig and Scheller, 1986) . However, labeling using a single amino acid has the advantage of keeping the number of labeled peptides at a manageable level. Even with this advantage, it was necessary to develop special HPLC gradients to resolve all the peptides observed in this study.
The motor neuron found to have the most complex synthesis pattern in the present study was B7, which expresses the FMRFamide, myomodulin, and SCP patterns of synthesis. There is reason to believe that even this is an underestimate of its complexity because B7 has also been shown to be immunoreactive with antisera directed towards the shared carboxyl terminals of gastrin and cholecystokinin (CCK; Ono, 1986) . Of the peptides we have observed to be synthesized in B7, only FMRFamide (Phe-Met-Arg-Phe-amide)
shows sequence similarity to the carboxyl terminals of gastrin and CCK (-Trp-MetAsp-Phe-amide). However, the gastrin/CCK-directed antisera do not cross-react with FMRFamide because other known FMRFamide-containing neurons do not stain with these antisera. Although it has been shown that the immunoreac!ivity in B7 is not associated with authentic gastrin or CCK (Ono, 1986) these results do suggest, as discussed earlier, that it is likely that the ventral-cluster motor neurons contain other as yet uncharacterized peptides.
The physiological and behavioral implications of the expression of such a variety of neuropeptides in buccal motor neurons must await detailed physiological studies such as those carried out for the SCPs in B 15 Lloyd, 1989, 1990; Cropper et al., 1990) . However, several generalizations can be drawn from our results: Neurons that innervate the same muscle fibers often synthesize different peptides. This observation is consistent with earlier results from studies of peptides synthesized by motor neurons innervating muscle I5 (Cropper et al., 1987a . Our present findings are also consistent with previous results from experiments in which peptides synthesized in the buccal ganglia and transported to buccal muscles were examined (Lloyd, 1988) . One ofthe major observations was that myomodulin was transported in large amounts to muscles I4 and 16 primarily via the radular nerves. In the present study, both identified motor neurons, which innervate I4 and I6 via the radular nerve, synthesize myomodulin. In addition, in the transport study, only the relatively small I5 muscle received amounts of labeled buccalin comparable to the other peptides and received essentially no FMRFamide. In our present study, the I5 motor neurons (B 15 and B 16) synthesized no FMRFamide and were the only neurons found to synthesize significant quantities of buccalin. The similarities in the results from these 2 studies raise the possibility that a significant amount of the peptides transported to buccal muscles may be synthesized in the motor neurons themselves. However, at least some of the peptides found to be transported to muscle from buccal ganglia are likely to be from neurons other than those in the ventral cluster. For example, previous results indicate that a number of small neurons that have peripheral axons and are thought to be sensory neurons (Fiore and Geppetti, 1980 ) also synthesize FMRFamide (Lloyd et al., 1987b) . In addition, another group of small neurons with peripheral axons contains SCP-like immunoreactivity Miller et al., 1988) .
Neurons in the buccal ganglia that express a particular peptide show a moderate degree of organization. The esophageal cluster is the predominant cluster of neurons that synthesize peptides. All neurons in this cluster, which includes neurons Bl and B2, synthesize the SCPs . Bl and B2 send their axons out the esophageal nerve and have been shown to regulate gut motility during feeding . In the present study, we have identified another discrete cluster of about 5 medium-sized neurons, including B8a, B8b, and B45, that synthesizes myomodulin and another peptide likely to be myomod-ulin B. There are also 2 clusters of more loosely associated neurons. One consists of 4 medial large neurons that synthesize FMRFamide, while a second, loose cluster consists of 5 large neurons that synthesize the SCPs (Fig. 2) . It would be interesting to determine ifthese associations ofneurons expressing the same peptide transmitters have a functional or developmental explanation.
Coexistence of modulatory neuropeptides with conventional transmitters has been reported previously in invertebrates (Bishop et al., 1984; Schwarz et al., 1984; Kuhlman et al., 1985; O'Shea and Schaffer, 1985) , as well as in vertebrates (Gibson et al., 1984; Ch'ng et al., 1985; New and Mudge, 1986) . Furthermore, in a number of instances, there is evidence that these neuropeptides may modulate several aspects of neuromuscular transmission (Adams and O'Shea, 1983; New and Mudge, 1986; Bishop et al., 1987; Mulle et al., 1988; Calabrese, 1989) . Thus, modulation by peptides released from motor neuron terminals may be phylogenetically widespread.
Although previous physiological studies with buccal motor neurons were directed specifically towards the SCPs in I5 muscle Lloyd, 1989, 1990; Cropper et al., 1990) , there is good reason to believe modulation by the SCPs and other peptides is widespread in other buccal muscles. First, the rates at which the SCPs, FMRFamide, and myomodulin are synthesized in buccal ganglia and transported to buccal muscles were roughly similar (Lloyd, 1988) . Second, every buccal motor neuron analyzed in the present study contains and synthesizes modulatory peptides. Thus, modulation of buccal muscle contractions by peptide cotransmitters released from motor neurons may contribute significantly to the behavioral plasticity observed during feeding in Aplysia (Susswein et al., 1978) .
The present study has identified motor neurons that synthesize modulatory peptides, and the muscles innervated by these neurons. This may prove to be an advantageous preparation to study cotransmission because these neurons have discrete identified targets and express a variety of peptide cotransmitters. These results should prove useful in directing future physiological experiments.
